Hypertrophic Obesity and Subcutaneous Adipose Tissue Dysfunction

BACKGROUND: Over the past 50 years, scientists have recognized that not all adipose tissue is alike, and that health risk is associated with the location as well as the amount of body fat. Different depots are sufficiently distinct with respect to fatty-acid storage and release as to probably play u...

Full description

Bibliographic Details
Main Authors: Anna Meiliana, Andi Wijaya
Format: Article
Language:English
Published: Secretariat of The Indonesian Biomedical Journal 2014-08-01
Series:Indonesian Biomedical Journal
Online Access:http://inabj.org/index.php/ibj/article/view/33
id doaj-28701d5451ec4388ae186a7797d5725b
record_format Article
spelling doaj-28701d5451ec4388ae186a7797d5725b2020-11-24T22:55:58ZengSecretariat of The Indonesian Biomedical JournalIndonesian Biomedical Journal2085-32972355-91792014-08-0162799010.18585/inabj.v6i2.3324Hypertrophic Obesity and Subcutaneous Adipose Tissue DysfunctionAnna Meiliana0Andi Wijaya1Postgraduate Program in Clinical Pharmacy, Padjadjaran University Jl. Eijkman No.38, BandungProdia Clinical Laboratory Jl. Cisangkuy No.2, BandungBACKGROUND: Over the past 50 years, scientists have recognized that not all adipose tissue is alike, and that health risk is associated with the location as well as the amount of body fat. Different depots are sufficiently distinct with respect to fatty-acid storage and release as to probably play unique roles in human physiology. Whether fat redistribution causes metabolic disease or whether it is a marker of underlying processes that are primarily responsible is an open question. CONTENT: The limited expandability of the subcutaneous adipose tissue leads to inappropriate adipose cell expansion (hypertrophic obesity) with local inflammation and a dysregulated and insulin-resistant adipose tissue. The inability to store excess fat in the subcutaneous adipose tissue is a likely key mechanism for promoting ectopic fat accumulation in tissues and areas where fat can be stored, including the intra-abdominal and visceral areas, in the liver, epi/pericardial area, around vessels, in the myocardium, and in the skeletal muscles. Many studies have implicated ectopic fat accumulation and the associated lipotoxicity as the major determinant of the metabolic complications of obesity driving systemic insulin resistance, inflammation, hepatic glucose production, and dyslipidemia. SUMMARY: In summary, hypertrophic obesity is due to an impaired ability to recruit and differentiate available adipose precursor cells in the subcutaneous adipose tissue. Thus, the subcutaneous adipose tissue may be particular in its limited ability in certain individuals to undergo adipogenesis during weight increase. Inability to promote subcutaneous adipogenesis under periods of affluence would favor lipid overlow and ectopic fat accumulation with negative metabolic consequences. KEYWORDS: obesity, adipogenesis, subcutaneous adipose tissue, visceral adipose tissue, adipocyte dysfunction.http://inabj.org/index.php/ibj/article/view/33
collection DOAJ
language English
format Article
sources DOAJ
author Anna Meiliana
Andi Wijaya
spellingShingle Anna Meiliana
Andi Wijaya
Hypertrophic Obesity and Subcutaneous Adipose Tissue Dysfunction
Indonesian Biomedical Journal
author_facet Anna Meiliana
Andi Wijaya
author_sort Anna Meiliana
title Hypertrophic Obesity and Subcutaneous Adipose Tissue Dysfunction
title_short Hypertrophic Obesity and Subcutaneous Adipose Tissue Dysfunction
title_full Hypertrophic Obesity and Subcutaneous Adipose Tissue Dysfunction
title_fullStr Hypertrophic Obesity and Subcutaneous Adipose Tissue Dysfunction
title_full_unstemmed Hypertrophic Obesity and Subcutaneous Adipose Tissue Dysfunction
title_sort hypertrophic obesity and subcutaneous adipose tissue dysfunction
publisher Secretariat of The Indonesian Biomedical Journal
series Indonesian Biomedical Journal
issn 2085-3297
2355-9179
publishDate 2014-08-01
description BACKGROUND: Over the past 50 years, scientists have recognized that not all adipose tissue is alike, and that health risk is associated with the location as well as the amount of body fat. Different depots are sufficiently distinct with respect to fatty-acid storage and release as to probably play unique roles in human physiology. Whether fat redistribution causes metabolic disease or whether it is a marker of underlying processes that are primarily responsible is an open question. CONTENT: The limited expandability of the subcutaneous adipose tissue leads to inappropriate adipose cell expansion (hypertrophic obesity) with local inflammation and a dysregulated and insulin-resistant adipose tissue. The inability to store excess fat in the subcutaneous adipose tissue is a likely key mechanism for promoting ectopic fat accumulation in tissues and areas where fat can be stored, including the intra-abdominal and visceral areas, in the liver, epi/pericardial area, around vessels, in the myocardium, and in the skeletal muscles. Many studies have implicated ectopic fat accumulation and the associated lipotoxicity as the major determinant of the metabolic complications of obesity driving systemic insulin resistance, inflammation, hepatic glucose production, and dyslipidemia. SUMMARY: In summary, hypertrophic obesity is due to an impaired ability to recruit and differentiate available adipose precursor cells in the subcutaneous adipose tissue. Thus, the subcutaneous adipose tissue may be particular in its limited ability in certain individuals to undergo adipogenesis during weight increase. Inability to promote subcutaneous adipogenesis under periods of affluence would favor lipid overlow and ectopic fat accumulation with negative metabolic consequences. KEYWORDS: obesity, adipogenesis, subcutaneous adipose tissue, visceral adipose tissue, adipocyte dysfunction.
url http://inabj.org/index.php/ibj/article/view/33
work_keys_str_mv AT annameiliana hypertrophicobesityandsubcutaneousadiposetissuedysfunction
AT andiwijaya hypertrophicobesityandsubcutaneousadiposetissuedysfunction
_version_ 1725655551217500160